Health Condition 1: null- Children with signs of scorpion sting envenomation
Conditions
Interventions
Intervention1: Haffkine Biopharma monovalent scorpion antivenom: dose of 3 vials (30 mg) - 30 ml dose will be added to 100 mL of normal saline, which will be infused intravenously over 30 minutes as s
Sponsors
The Director
Eligibility
Inclusion criteria
Inclusion criteria: All children <= 12 years presenting with features of scorpion sting envenomation or unknown bite consistent with clinical features of scorpion sting envenomation.
Exclusion criteria
Exclusion criteria: Children without systemic features of scorpion sting envenomation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To see if second dose of antiscorpion venom (SAV) help in the recovery of children with non-resolving scorpion sting envenomation â?? grade 2 and above.Timepoint: To see if second dose of antiscorpion venom (SAV) help in the recovery of children with non-resolving scorpion sting envenomation â?? grade 2 and above. | — |
Secondary
| Measure | Time frame |
|---|---|
| To find the factors causing the delay in recovery of symptoms /worsening or progression of signs of envenomation even after the use of first dose of SAVTimepoint: At end of 6 hours.;To study about the adverse effects of SAVTimepoint: At end of 6 hours. | — |
Countries
India
Contacts
Public ContactDr Ramesh Kumar R
JIPMER
Outcome results
None listed